SIRT1 and alcoholic fatty liver disease: In addition, the activated AMPK further activates SIRT1, which is one of the key markers for the treatment of diabetes‐related fatty liver and alcoholic fatty liver disease.36, 37 Our experimental results also showed that MH significantly inhibited the decline of sirt1 in T2D mice.